Unraveling lipid metabolism reprogramming for overcoming drug resistance in melanoma

Biochem Pharmacol. 2024 Mar 10;223:116122. doi: 10.1016/j.bcp.2024.116122. Online ahead of print.ABSTRACTCutaneous melanoma is the deadliest form of skin cancer, and its incidence is continuing to increase worldwide in the last decades. Traditional therapies for melanoma can easily cause drug resistance, thus the treatment of melanoma remains a challenge. Various studies have focused on reversing the drug resistance. As tumors grow and progress, cancer cells face a constantly changing microenvironment made up of different nutrients, metabolites, and cell types. Multiple studies have shown that metabolic reprogramming of cancer is not static, but a highly dynamic process. There is a growing interest in exploring the relationship between melanoma andmetabolic reprogramming, one of which may belipid metabolism. This review frames the recent research progresses on lipid metabolism in melanoma.In addition, we emphasize the dynamic ability of metabolism during tumorigenesis as a target for improving response to different therapies and for overcoming drug resistance in melanoma.PMID:38467377 | DOI:10.1016/j.bcp.2024.116122
Source: Biochemical Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research